Professor He has accumulated four decades of pioneering research experience in the field of immunology. Moreover, for the past 15 years, he has been dedicated to the clinical immunotherapy in oncology, yielding breakthrough outcomes in cancer treatment.

•TenuredFullProfessor,DepartmentofImmunology,DukeUniversityMedicalCenter

•SpecialExpertfortheNationalVaccineProgram,U.S.DepartmentofHealthandHumanServices;GrantReviewExpertfortheNationalInstitutesofHealth(NIH);MemberoftheAmericanAssociationofImmunologists(AAI)

•ScientificContributions:With40yearsofimmunologicalresearch,including25yearsofteachingandresearchatDukeUniversity,ProfessorHehaspublished170articlesinleadinginternationaljournalswithacumulativeImpactFactor(IF)exceeding1500.HehaswonResearchScholarAwardfromtheAmericanCancerSociety.Hispioneeringcontributionsencompassthemolecularmechanismsofimmunecellapoptosis,immunerecognitionoftumorsandpathogenicinfections,andenhancingthediversityandefficacyofantigenpresentation.

•EditorialLeadership:SectionEditor-in-ChiefforFrontiersinCellandDevelopmentalBiology–CellDeathandSurvivalSection;EditorialBoardMemberforImmunology,CellularandMolecularImmunology,andScientificReports.PreviouslyservedontheEditorialBoardsoftheJournalofImmunologyandtheJournalofBiologicalChemistry,andasAssociateEditorofAutophagy.Hehasservedasareviewerforover30world-renownedjournals,includingNature,Science,andNatureImmunology.

•Professor He has served as aOverall Expert for the National Major Infectious Disease Program, Director of the Immunotherapy Center at the National Molecular Medicine Translation Center, and Distinguished Professor at the Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College. He has held research positions at the Institute of Zoology, Chinese Academy of Sciences (CAS), and has been a member of the CAS Overseas Expert Team for Primate Models of Human Diseases. He is a Distinguished Professor at Jinan University, Cheung Kong Scholar Chair Professor appointed by the Ministry of Education, Visiting Professor at the Institute of Immunology, Zhejiang University School of Medicine, and Visiting Professor at China Medical University, having trained numerous talents in the life sciences.

•Over the past 15 years, Professor He has been dedicated to clinical cancer immunotherapy. He pioneered the world's first "Individualized and Precision Immunotherapy for Brain Tumors" clinical study at the Affiliated Hospital of Jinan University. He currently leads five cancer immunotherapy clinical studies at XijingHospital, Beijing TiantanHospital, and Shanghai General Hospital, achieving breakthrough results. His core technologies have received multiple prestigious awards including the "Innovation China Pioneering Technology Roster" and the Ministry of Science and Technology's "Disruptive Technology" award.